These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 3928305
21. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors. Ford NF, Browne LJ, Campbell T, Gemenden C, Goldstein R, Gude C, Wasley JW. J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169 [Abstract] [Full Text] [Related]
22. Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensions. Needleman P, Bryan B, Wyche A, Bronson SD, Eakins K, Ferrendelli JA, Minkes M. Prostaglandins; 1977 Nov; 14(5):897-907. PubMed ID: 594391 [Abstract] [Full Text] [Related]
30. Effects of selective inhibition of thromboxane synthesis on renal function in humans. Zipser RD. Am J Physiol; 1985 Jun; 248(6 Pt 2):F753-6. PubMed ID: 3839111 [Abstract] [Full Text] [Related]
33. Differential effects of cyclo-oxygenase inhibitors and thromboxane synthase inhibitors on rabbit platelet aggregation: evidence for the importance of prostaglandin endoperoxides as mediators in arachidonate-induced aggregation but not in collagen-induced aggregation. Wallis RB, Zelaschi D. Biochem Soc Trans; 1980 Dec; 8(6):726-7. PubMed ID: 6780392 [No Abstract] [Full Text] [Related]
34. A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors. Fitzpatrick FA, Gorman RR. Biochim Biophys Acta; 1978 Mar 01; 539(2):162-72. PubMed ID: 629996 [Abstract] [Full Text] [Related]